Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab for Flare Prevention in SLE Patients With Low Disease Activity
NCT04515719Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Mar 2021
- Primary completion
- Apr 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by Renji Hospital. Started Mar 2021; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04515719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515719.